Alnylam Pharmaceuticals Inc 2022 Sustainability Report
Company: Alnylam Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2022
Type: Sustainability Report
Pages: 62
The report highlights Alnylam's launch of its fifth product within four years and its achievement of all six MassBio DE&I pledge goals. It describes expansion of the Alnylam Challengers community impact initiative into European teams supporting refugees. The company also published restated 2020 and 2021 Scope 1 and 2 emissions, selected Scope 3 categories, water-use data, and waste data, with independent third-party verification of environmental data. It reports 2,011 employees globally and five female board members in its December 2022 snapshot.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.